Last updated on March 2018

Non-Interventional Post-Marketing Safety Study on the Long-Term Safety of HYQVIA (Global)


Brief description of study

The purpose of the proposed study is to acquire additional data (including the assessment of anti-rHuPH20 antibodies) on the long-term safety of HYQVIA and to assess the prescribed treatment regimens and treatment administration in routine clinical practice.

Clinical Study Identifier: NCT02593188

Contact Investigators or Research Sites near you

Start Over

Salvador Dominguez

Allergy & Clinical Immunology Associates
Pittsburgh, PA United States
2.31miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.